Thomas C. Smyrk

83.7k total citations · 8 hit papers
449 papers, 28.4k citations indexed

About

Thomas C. Smyrk is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas C. Smyrk has authored 449 papers receiving a total of 28.4k indexed citations (citations by other indexed papers that have themselves been cited), including 220 papers in Surgery, 184 papers in Oncology and 112 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas C. Smyrk's work include Genetic factors in colorectal cancer (99 papers), Colorectal Cancer Screening and Detection (71 papers) and Pancreatic and Hepatic Oncology Research (68 papers). Thomas C. Smyrk is often cited by papers focused on Genetic factors in colorectal cancer (99 papers), Colorectal Cancer Screening and Detection (71 papers) and Pancreatic and Hepatic Oncology Research (68 papers). Thomas C. Smyrk collaborates with scholars based in United States, Italy and Canada. Thomas C. Smyrk's co-authors include Suresh T. Chari, Henry T. Lynch, Lizhi Zhang, Naoki Takahashi, Randall K. Pearson, Jonathan E. Clain, Bret T. Petersen, Tom R. DeMeester, Mark Topazian and Patrice Watson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Thomas C. Smyrk

437 papers receiving 27.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

1997 814 citations C. Richard Boland, Thomas C. Smyrk et al. profile →
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review

1993 792 citations Henry T. Lynch, Thomas C. Smyrk et al. Gastroenterology profile →
Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience

2006 686 citations Suresh T. Chari, Thomas C. Smyrk et al. profile →
Esophageal eosinophilia with dysphagia

1993 637 citations Stephen E. Attwood, Thomas C. Smyrk et al. profile →
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy

2008 595 citations Suresh T. Chari, Thomas C. Smyrk et al. Gastroenterology profile →
Rituximab for IgG4-related disease: a prospective, open-label trial

2015 444 citations Mark Topazian, Thomas C. Smyrk et al. profile →
Epidemiology of Eosinophilic Esophagitis Over Three Decades in Olmsted County, Minnesota

2009 376 citations Thomas C. Smyrk et al. profile →
A Controlled Trial of Gluten-Free Diet in Patients With Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal Function

2013 324 citations Thomas C. Smyrk, Joseph A. Murray et al. Gastroenterology profile →

Peers

Countries citing papers authored by Thomas C. Smyrk

Since Specialization

Citations

This map shows the geographic impact of Thomas C. Smyrk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Smyrk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Smyrk more than expected).

Fields of papers citing papers by Thomas C. Smyrk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Smyrk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Smyrk. The network helps show where Thomas C. Smyrk may publish in the future.

Co-authorship network of co-authors of Thomas C. Smyrk

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Smyrk. A scholar is included among the top collaborators of Thomas C. Smyrk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Smyrk. Thomas C. Smyrk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CT findings in idiopathic myointimal hyperplasia of mesenteric veins (IMHMV) and comparison to other colitides 2023 ·Abdominal Radiology ·(unknown), Shannon P. Sheedy, Jay P. Heiken, Rondell P. Graham, Roger K. Moreira, Thomas C. Smyrk, Seth Sweetser, Jeff L. Fidler	1
2	BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease 2021 ·Journal of Clinical Investigation ·(unknown), Adebowale O. Bamidele, Phyllis A. Svingen, (unknown), Thomas C. Smyrk, (unknown), Feda H. Hamdan, Robyn Laura Kosinsky, (unknown), Zhifu Sun, Zhenqing Ye, Asha Nair, Guilherme Piovezani Ramos, Manuel B. Braga Neto, (unknown), Angela Mathison, Steven A. Johnsen, Raúl Urrutia, William A. Faubion	16
3	Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma 2019 ·Clinical Cancer Research ·Yi Qin, Chung Wah Wu, William R. Taylor, Tarek Sawas, Kelli N. Burger, Douglas W. Mahoney, Zhifu Sun, Tracy C. Yab, Graham P. Lidgard, Hatim T. Allawi, Navtej Buttar, Thomas C. Smyrk, Prasad G. Iyer, David A. Katzka, David A. Ahlquist, John B. Kisiel	40
4	Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma 2018 ·Clinical Cancer Research ·(unknown), Yun‐Suhk Suh, Boram Choi, Hyuk‐Joon Lee, Tracy C. Yab, William R. Taylor, Brian A. Dukek, Calise K. Berger, (unknown), Patrick H. Foote, Mary E. Devens, Lisa A. Boardman, John B. Kisiel, Douglas W. Mahoney, Seth W. Slettedahl, Hatim T. Allawi, Graham P. Lidgard, Thomas C. Smyrk, Han‐Kwang Yang, David A. Ahlquist	47
5	North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic‐based dosing of irinotecan, oxaliplatin, and capecitabine as first‐line therapy for patients with advanced small bowel adenocarcinoma 2017 ·Cancer ·Robert R. McWilliams, Nathan R. Foster, Michelle R. Mahoney, Thomas C. Smyrk, Joseph A. Murray, Matthew M. Ames, Laura E. Horvath, Daniel Schneider, Timothy J. Hobday, Aminah Jatoi, Jeffrey P. Meyers, Matthew P. Goetz	31
6	Shifts in the Fecal Microbiota Associated with Adenomatous Polyps 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Vanessa L. Hale, Jun Chen, Stephen Johnson, Sean C. Harrington, Tracy C. Yab, Thomas C. Smyrk, Heidi Nelson, Lisa A. Boardman, Brooke R. Druliner, Theodore R. Levin, Douglas K. Rex, Dennis J. Ahnen, Peter Lance, David A. Ahlquist, Nicholas Chia	149
7	Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study 2016 ·Gut ·Thomas G. Cotter, Moritz Binder, Edward V. Loftus, (unknown), (unknown), Thomas C. Smyrk, William J. Tremaine, William J. Sandborn, Darrell S. Pardi	26
8	Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Anna E. Prizment, Robert A. Vierkant, Thomas C. Smyrk, Lori S. Tillmans, Heather H. Nelson, Charles F. Lynch, Thomas Pengo, Stephen N. Thibodeau, Timothy R. Church, James R. Cerhan, Kristin E. Anderson, Paul J. Limburg	40
9	Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance) 2015 ·Clinical Cancer Research ·Frank A. Sinicrope, Michelle R. Mahoney, Harry H. Yoon, Thomas C. Smyrk, Stephen N. Thibodeau, Richard M. Goldberg, Garth D. Nelson, Daniel J. Sargent, Steven R. Alberts	66
10	New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice 2015 ·Clinical Cancer Research ·John B. Kisiel, Massimo Raimondo, William R. Taylor, Tracy C. Yab, Douglas W. Mahoney, Zhifu Sun, Sumit Middha, Saurabh Baheti, Hongzhi Zou, Thomas C. Smyrk, Lisa A. Boardman, Gloria M. Petersen, David A. Ahlquist	92
11	Pancreatic Cancer–Derived Exosomes Cause Paraneoplastic β-cell Dysfunction 2014 ·Clinical Cancer Research ·Naureen Javeed, Gunisha Sagar, Shamit K. Dutta, Thomas C. Smyrk, Julie S. Lau, Santanu Bhattacharya, Mark J. Truty, Gloria M. Petersen, Randal J. Kaufman, Suresh T. Chari, Debabrata Mukhopadhyay	150
12	Demystifying seronegative autoimmune pancreatitis 2012 ·Pancreatology ·Gokulakrishnan Balasubramanian, Aravind Sugumar, Thomas C. Smyrk, Naoki Takahashi, Jonathan E. Clain, Ferga C. Gleeson, Phil A. Hart, Michael J. Levy, Randall K. Pearson, Bret T. Petersen, Mark Topazian, Santhi Swaroop Vege, Suresh T. Chari	13
13	Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women 2011 ·Gut ·David Limsui, Robert A. Vierkant, Lori S. Tillmans, Alice H. Wang, Daniel J. Weisenberger, Peter W. Laird, Charles F. Lynch, Kristin E. Anderson, Amy J. French, Robert W. Haile, Lisa Harnack, John D. Potter, Susan L. Slager, Thomas C. Smyrk, Stephen N. Thibodeau, James R. Cerhan, Paul J. Limburg	32
14	Protein Kinase Cι Is Required for Pancreatic Cancer Cell Transformed Growth and Tumorigenesis 2010 ·Cancer Research ·(unknown), William R. Bamlet, Thomas C. Smyrk, Alan P. Fields, Nicole R. Murray	88
15	PROLIFERATION AND APOPTOSIS BIOMARKER MODULATION IN A PHASE II COLORECTAL (CRC) CHEMOPREVENTION TRIAL OF ATORVASTATIN, SULINDAC, OR OLIGOFRUCTOSE-ENRICHED INLULIN: A CANCER PREVENTION NETWORK (CPN) TRIAL 2010 ·Annals of Oncology ·(unknown), Thomas C. Smyrk, (unknown), Russell I. Heigh, Robert E. Schoen, J Levine, Elena M. Stoffel, Michael Chiorean, (unknown), (unknown), (unknown), Michael Lawson, C. J. Gostout, (unknown), Paul J. Limburg	2
16	Expression and Regulatory Role of GAIP-Interacting Protein GIPC in Pancreatic Adenocarcinoma 2006 ·Cancer Research ·Michael H. Muders, Shamit K. Dutta, Ling Wang, Julie S. Lau, Resham Bhattacharya, Thomas C. Smyrk, Suresh T. Chari, Kaustubh Datta, Debabrata Mukhopadhyay	37
17	Cancer-associated genodermatoses 2003 ·Marcia S. Brose, Thomas C. Smyrk, Barbara L. Weber, Henry T. Lynch	8
18	Genetic counseling in a navajo hereditary nonpolyposis colorectal cancer kindred 1996 ·Cancer ·Henry T. Lynch, (unknown), Hans F. A. Vasen, Jennifer Cavalieri, Jane F. Lynch, (unknown), Thomas C. Smyrk, Stephen J. Lanspa, Patricia D. Murphy, (unknown), June A. Peters, Albert de la Chapelle	23
19	Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review breakdown → 1993 ·Gastroenterology ·Henry T. Lynch, Thomas C. Smyrk, Patrice Watson, Stephen J. Lanspa, Jane F. Lynch, Patrick M. Lynch, R. Jennifer Cavalieri, C. Richard Boland	792
20	Surgical Therapy in Barrettʼs Esophagus 1990 ·Annals of Surgery ·Tom R. DeMeester, Stephen E. Attwood, Thomas C. Smyrk, (unknown), Ronald A. Hinder	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact